Profil
Ulf Sewerin is currently the Chief Executive Officer at AddBIO AB since 2012.
Prior to this, he worked as a Director at Doxa AB.
Postes actifs de Ulf Sewerin
| Sociétés | Poste | Début |
|---|---|---|
AddBIO AB
 AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Directeur Général | 31/08/2012 |
Anciens postes connus de Ulf Sewerin
| Sociétés | Poste | Fin |
|---|---|---|
| DOXA AB | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DOXA AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
AddBIO AB
AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Health Technology |
